Clinimetrics of the Italian version of the Montreal Cognitive Assessment (MoCA) in adult-onset idiopathic focal dystonia
- PMID: 37308662
- PMCID: PMC10682121
- DOI: 10.1007/s00702-023-02663-0
Clinimetrics of the Italian version of the Montreal Cognitive Assessment (MoCA) in adult-onset idiopathic focal dystonia
Abstract
This study aimed at assessing the clinimetrics of the Montreal Cognitive Assessment (MoCA) in an Italian cohort of patients with adult-onset idiopathic focal dystonia (AOIFD). N = 86 AOIFD patients and N = 92 healthy controls (HCs) were administered the MoCA. Patients further underwent the Trail-Making Test (TMT) and Babcock Memory Test (BMT), being also screened via the Beck Depression Inventory-II (BDI-II) and the Dimensional Apathy Scale (DAS). Factorial structure and internal consistency were assessed. Construct validity was tested against TMT, BMT, BDI-II and DAS scores, whilst diagnostics against the co-occurrence of a defective performance on at least one TMT measure and on the BMT. Case-control discrimination was examined. The association between MoCA scores and motor-functional measures was explored. The MoCA was underpinned by a mono-component structure and acceptably reliable at an internal level. It converged towards TMT and BMT scores, as well as with the DAS, whilst diverging from the BDI-II. Its adjusted scores accurately detected cognitive impairment (AUC = .86) at a cut-off of < 17.212. The MoCA discriminated patients from HCs (p < .001). Finally, it was unrelated to disease duration and severity, as well as to motor phenotypes. The Italian MoCA is a valid, diagnostically sound and feasible cognitive screener in AOIFD patients.
Keywords: Cognitive screening; Dystonia; Hyperkinetic; Montreal Cognitive Assessment; Movement disorders; Neuropsychology.
© 2023. The Author(s).
Conflict of interest statement
V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of
Figures

Similar articles
-
Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.Neurol Sci. 2024 Mar;45(3):1079-1086. doi: 10.1007/s10072-023-07070-7. Epub 2023 Sep 28. Neurol Sci. 2024. PMID: 37770762
-
Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.Aging Clin Exp Res. 2023 Oct;35(10):2157-2163. doi: 10.1007/s40520-023-02493-w. Epub 2023 Jul 22. Aging Clin Exp Res. 2023. PMID: 37480503 Free PMC article.
-
Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson's disease patients.J Neural Transm (Vienna). 2023 May;130(5):687-696. doi: 10.1007/s00702-023-02624-7. Epub 2023 Mar 28. J Neural Transm (Vienna). 2023. PMID: 36976351
-
Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.Psychiatr Pol. 2016 Oct 31;50(5):1039-1052. doi: 10.12740/PP/45368. Psychiatr Pol. 2016. PMID: 27992895 Review. English, Polish.
-
Conversion between the Montreal Cognitive Assessment and the Mini-Mental Status Examination.J Am Geriatr Soc. 2023 Mar;71(3):869-879. doi: 10.1111/jgs.18124. Epub 2022 Nov 8. J Am Geriatr Soc. 2023. PMID: 36346002
Cited by
-
On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.J Alzheimers Dis. 2024;101(1):293-308. doi: 10.3233/JAD-240339. J Alzheimers Dis. 2024. PMID: 39150828 Free PMC article.
References
-
- Aiello EN, Gramegna C, Esposito A, Gazzaniga V, Zago S, Difonzo T, et al. The montreal cognitive assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy. Aging Clin Exp Res. 2022;34:375–382. doi: 10.1007/s40520-021-01943-7. - DOI - PMC - PubMed